Sushil Patel
Chief Executive Officer bei REPLIMUNE GROUP, INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Sushil Patel
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REPLIMUNE GROUP, INC. | Director/Board Member | 01.04.2024 | - |
| Chief Executive Officer | 01.04.2024 | - | |
| Public Communications Contact | 03.05.2021 | 03.01.2023 | |
| Corporate Officer/Principal | 03.01.2023 | 01.04.2024 | |
| REVOLUTION MEDICINES, INC. | Director/Board Member | 16.06.2022 | - |
| Independent Dir/Board Member | 16.06.2022 | - |
Karriereverlauf von Sushil Patel
Ehemalige bekannte Positionen von Sushil Patel
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.04.2008 | 01.05.2021 |
Ausbildung von Sushil Patel
| Imperial College London | Graduate Degree |
| University of London | Doctorate Degree |
| University of Warwick | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 4 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| REVOLUTION MEDICINES, INC. | Health Technology |
| REPLIMUNE GROUP, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Sushil Patel
- Erfahrung
